Botulinum toxin: Therapeutic agent to cosmetic enhancement to lethal biothreat

Anaerobe

Volumn 18, Issue 2, 2012, Pages 240-243

  Katona, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biothreat; Botulinum neurotoxin; Clostridium botulinum

Indexed keywords

BOTULINUM TOXIN; COSMETIC;

ANTHRAX; ARTICLE; BACTERIAL STRAIN; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM BOTULINUM TYPE A; CLOSTRIDIUM BOTULINUM TYPE B; CLOSTRIDIUM BOTULINUM TYPE E; CLOSTRIDIUM BOTULINUM TYPE F; ELECTROCHEMICAL ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT TOLERANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; SMALLPOX; TERRORISM; THREAT;

BIOLOGICAL WARFARE AGENTS; BOTULINUM TOXINS; CLOSTRIDIUM BOTULINUM; COSMETICS; HUMANS;

CLOSTRIDIUM BOTULINUM; VARIOLA VIRUS;

EID: 84859869827     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.12.001     Document Type: Article

References (28)

1. National Select Agent Registry. [accessed 02.12.11]. http://www.selectagents.gov/select%2520agents%2520and%2520Toxins%2520list.html.
2. Coleman K., Zilinskas R. Fake botox, real threat. Scientific American June 2010, 85-89.
3. Manitoba Public health Communicable Disease Management Protocol. [accessed 30.11.11]. http://www.gov.mb.ca/health/publichealth/cdc/protocol/botulism.pdf.
4. Chin J. Control of communicable disease 2000, American Public Health Assn, p. 70-75. 7th ed....
5. Setlowa P. I will survive: DNA protection in bacterial spores. Trends in Microbiology 2007, 15(4):172-180.
6. [assessed 02.12.11]. http://bestpractice.bmj.com/best-practice/monograph/810/basics/pathophysiology.html.
7. Weber J.T. Botulism. Infectious diseases 1994, 1185-1194. J.B. Lippincott Company. 5th ed. P.D. Hpeprich (Ed.).
8. HHS awards bioshield contract for botulism antitoxin June 1, 2006, HHS Archive, Department of Health and Human Services, [assessed 02.07.11].
9. Brook I. Infant botulism. Journal of Perinatology 2007, 27(3):175-180.
10. Young J.H. Botulism and the ripe olive scare of 1919-1920. Bulletin of the History of Medicine 1976, 50:372-391.
11. van Ermengen E. Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Z Hyg Infektionskrankh 1897, 26:1-56. (as reported in Mandel 5th ed. p. 2543).
12. Davis J.B., Mattman L.H., Wiley M. Clostridium botulinum in a fatal wound infection. JAMA 1951, 146:646-648.
13. Madura T.F., Armon S.S. Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet 1976, 2:934-936.
14. Thacker Steven CDC private communication November 19, 2011.
15. Sachdev N. Avian botulism may lead to extreme bird deaths around Alberta, warn experts [assessed 20.10.11]. http://www.FrenchTribune.com.
16. Avian botulism in Alberta, Canada reported in ProMed [assessed 16.10.11]. http://www.frenchtribune.com/teneur/116660-avian-botulism-may-lead-extreme-bird-deaths-around-alberta-warn-experts.
17. Arnon S.S., Schechter R., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001, 285:1059-1070.
18. EV Hill. Botulism. in: Summary report on B. W. Investigations. Memorandum to General Alden cC Waitt, Chief, Chemical Corps, Department of the Army, December 12, 1947. Table D. Archived at: the Library of Congress, Washington, DC.
19. Cochrane R.C. Biological warfare research in the United States. History of the chemical warfare service in world war II (01 July 1940-15 August 1945) 1947, vol. 2. Historical Section, Plans, Training and Intelligence Division, Office of the Chief, Chemical Corps, US Department of the Army, Fort Detrick, MD, Unclassified. Archived at: US Army Medical Research Institute of Infectious Diseases.
20. Alibek K. Biohazard 1999, Dell Publishing, New York.
21. Blix H. Disarming Iraq 2004, Pantheon Books, New York.
22. Center for Nonproliferation Studies Chronology of Aum Shinrikyo's CBW activities 2001, Monterey Institute of International Studies, Monterey, CA, [assessed 02.12.11]. http://cns.miis.edu/reports/aum_chrn.htm.
23. Simpson D.M. Clinical trials of botulinum toxin in the treatment of spasticity. Chapter 10 in Muscle and Nerve 7 Dec 1998, first published online.
24. Pickett A., Mewies M. Serious issues relating to the clinical use of unlicensed botulinum toxin products. Journal of the American Academy of Dermatology 2009, 61:149-150.
25. Warrick J. Terrorists want illegal Botox?. Hindustan Times January 26, 2010, [accessed 16.10.11]. http://www.hindustantimes.com/Terrorists-want-illegal-Botox/Article1-501805.aspx.
26. FDA law enforcers crack down on illegal Botox scammers FDA website, [accessed 16.10.11]. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048377.htm.
27. Warrick J. Officials fear toxic ingredient in Botox could become terrorist tool. Washington Post January 25, 2010, [accessed 16.10.11]. http://www.washingtonpost.com/wp-dyn/content/article/2010/01/24/AR2010012403013.html.
28. Kunal J., Rambhia A.S., Ribner A.S., Gronvall G.K. Everywhere you look: select agent pathogens. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2011, 9:69-71.